‘Risks Are Rising' for Nike and It's Time to Sell the Stock, Says Bank of America

Bank of America downgraded Nike to underperform from neutral and cut its price target to a Street-low $30 from $47, citing fading confidence in the turnaround, weak classics sales and mounting category and macro pressures. The bank now forecasts another sales decline in fiscal 2027, delaying a prospective recovery until fiscal 2028. Nike closed just under $36, down about 1% on Friday and more than 40% year to date, ahead of fiscal Q1 2027 earnings next Thursday.

Analysis

The relevant issue is not the downgrade itself but a likely reset in Nike's earnings-recovery duration. A further year of top-line contraction would force the market to underwrite a FY28 recovery while absorbing promotional activity, wholesale re-entry costs, and continued brand-demand investment; that combination risks both lower EPS estimates and a lower multiple. With sell-side targets still materially above the share price, the next earnings call is a high-risk estimate-convergence event rather than an obvious valuation floor.

Competitive spillover is asymmetric. Adidas (ADS.DE) and Deckers (DECK) can retain shelf space and premium running/lifestyle consumers if Nike's product cycle remains uneven, while On Holding (ONON) and Hoka/DECK benefit disproportionately from specialty-channel momentum. Foot Locker (FL) is less clear-cut: incremental Nike wholesale availability may aid traffic and inventory turns, but weak full-price demand would compress retailer markdown economics and offset volume gains.

Near term, a weak guide or evidence of sustained gross-margin pressure could drive another leg lower over days to one month, particularly if management again defers recovery milestones. The contrarian case is that expectations are already depressed and direct-to-consumer inventory discipline produces a gross-margin surprise; that would generate a sharp short-covering rally. The thesis is falsified by credible evidence that North America and China return to growth without stepped-up discounting, alongside maintained or improving gross-margin guidance.

Key Decisions for Investors

• Maintain a tactical short NKE into next Thursday's earnings only with defined risk; use a 1-2 month put spread rather than outright puts after checking implied volatility. Target a 10-15% downside on a FY27 revenue/EPS-guide reset; exit if management guides to revenue stabilization and gross-margin expansion.
• Pair trade over 1-3 months: long DECK or ONON versus short NKE in equal beta-adjusted dollars. This isolates premium footwear/category-share transfer from broad consumer discretionary risk; reassess if Nike shows sell-through improvement in running and wholesale channels.
• Avoid treating FL as a clean Nike-recovery proxy. Put FL on watch for post-earnings commentary on allocation, markdowns, and inventory turns; only consider a long if Nike supply improves while FL confirms full-price sell-through and margin protection.
• For longer-horizon capital, wait for independently observable turnaround markers before covering structural NKE shorts or initiating a long: two consecutive quarters of positive currency-neutral sales growth, inventory declining faster than sales, and no further FY28 recovery deferral.